Abstract:The identification of drug-target relations (DTRs) is substantial in drug development. A large number of methods treat DTRs as drug-target interactions (DTIs), a binary classification problem. The main drawback of these methods are the lack of reliable negative samples and the absence of many important aspects of DTR, including their dose dependence and quantitative affinities. With increasing number of publications of drug-protein binding affinity data recently, DTRs prediction can be viewed as a regression problem of drug-target affinities (DTAs) which reflects how tightly the drug binds to the target and can present more detailed and specific information than DTIs. The growth of affinity data enables the use of deep learning architectures, which have been shown to be among the state-of-the-art methods in binding affinity prediction. Although relatively effective, due to the black-box nature of deep learning, these models are less biologically interpretable. In this study, we proposed a deep learning-based model, named AttentionDTA, which uses attention mechanism to predict DTAs. Different from the models using 3D structures of drug-target complexes or graph representation of drugs and proteins, the novelty of our work is to use attention mechanism to focus on key subsequences which are important in drug and protein sequences when predicting its affinity. We use two separate one-dimensional Convolution Neural Networks (1D-CNNs) to extract the semantic information of drug's SMILES string and protein's amino acid sequence. Furthermore, a two-side multi-head attention mechanism is developed and embedded to our model to explore the relationship between drug features and protein features. We evaluate our model on three established DTA benchmark datasets, Davis, Metz, and KIBA. AttentionDTA outperforms the state-of-the-art deep learning methods under different evaluation metrics. The results show that the attention-based model can effectively extract protein features related to drug information and drug features related to protein information to better predict drug target affinities. It is worth mentioning that we test our model on IC50 dataset, which provides the binding sites between drugs and proteins, to evaluate the ability of our model to locate binding sites. Finally, we visualize the attention weight to demonstrate the biological significance of the model. The source code of AttentionDTA can be downloaded from https://github.com/zhaoqichang/AttentionDTA_TCBB.

PocketDTA: An advanced multimodal architecture for enhanced prediction of drug-target affinity from 3D structural data of target binding pockets.

Predicting Drug-Target Affinity Using Protein Pocket and Graph Convolution Network

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

DataDTA: a multi-feature and dual-interaction aggregation framework for drug–target binding affinity prediction

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

EMPDTA: An End-to-End Multimodal Representation Learning Framework with Pocket Online Detection for Drug–Target Affinity Prediction

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction

AttentionDTA: Drug-Target Binding Affinity Prediction by Sequence-Based Deep Learning with Attention Mechanism.

3DProtDTA: a deep learning model for drug-target affinity prediction based on residue-level protein graphs

Drug-target Binding Affinity Prediction Model Based on Multi-Scale Diffusion and Interactive Learning

Breaking the barriers of data scarcity in drug–target affinity prediction

MM-DRPNet: A Multimodal Dynamic Radial Partitioning Network for Enhanced Protein–Ligand Binding Affinity Prediction

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

ColdDTA: Utilizing data augmentation and attention-based feature fusion for drug-target binding affinity prediction

GTAMP-DTA: Graph transformer combined with attention mechanism for drug-target binding affinity prediction

DTA-GTOmega: Enhancing Drug-Target Binding Affinity Prediction with Graph Transformers Using OmegaFold Protein Structures

MFR-DTA: a multi-functional and robust model for predicting drug–target binding affinity and region

Drug3D-DTI: Improved Drug-target Interaction Prediction by Incorporating Spatial Information of Small Molecules